|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flow from operating activities | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Stock-based compensation expense | |||||
| Depreciation | |||||
| Loss on disposal of fixed assets | |||||
| Non-cash interest expense on liability for sale of future revenues | |||||
| Net accretion of discounts on marketable securities | |||||
| Interest related to sale of future revenues | |||||
| Impairment of held for sale assets | |||||
| Other non-cash items, net | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Prepaid expenses and other current assets | |||||
| Right-of-use assets | |||||
| Other non-current assets | |||||
| Accounts payable | |||||
| Accrued expenses | |||||
| Accrued interest on sale of future revenues | |||||
| Deferred revenue | |||||
| Operating lease liabilities | |||||
| Other current and non-current liabilities | |||||
| Other non-current liabilities | |||||
| Net cash used in operating activities | |||||
| Cash flow from investing activities | |||||
| Purchases of property and equipment | |||||
| Proceeds from the sale of equipment | |||||
| Purchases of marketable securities | |||||
| Proceeds from maturities of marketable securities | |||||
| Net cash provided by investing activities | |||||
| Cash flow from financing activities | |||||
| Repayment on sale of future revenues | |||||
| Proceeds from offering of common stock, net of issuance costs | |||||
| Proceeds from sale of future revenues, net | |||||
| Proceeds from exercise of stock options | |||||
| Issuance of common stock under benefit plans | |||||
| Net cash provided by financing activities | |||||
| Net increase (decrease) in cash, cash equivalents, and restricted cash | |||||
| Cash, cash equivalents, and restricted cash, beginning of period | |||||
| Cash, cash equivalents, and restricted cash, end of period | |||||
| Supplemental disclosure of cash and non-cash activities: | |||||
| Fixed asset additions included in accounts payable and accrued expenses | |||||
| Cash paid in connection with operating lease liabilities | |||||
| Remeasurement of operating lease liabilities and right-of-use assets due to lease modification | |||||
| Commencement of right-of-use asset | |||||
| Modification of right-of-use asset | |||||
| Non-cash termination of right-of-use asset | |||||
| Cash paid for interest | |||||
| Issuance costs associated with the sale of future revenues included in accounts payable and accrued expenses | |||||
| Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation | |||||
| Cash and cash equivalents, end of period | |||||
| Restricted cash |
Loading...